The winter season is often accompanied by health challenges. The cold air can contribute to various skin conditions, and it can dampen the immune system, leading to illness as well. Over the years, we have published some great information on compounding for this season in our members-only magazine, the Apothagram, so we decided to share some of that information in our latest blog post!

PCCA's Matt Martin and Melissa Merrell Rhoads provide an update on the FDA's decision to designate human chorionic gonadotropin (HCG) as a biologic product and what that means for compounders and for PCCA.

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.